Paradigm Peptide
Tirzepatide
Finnrick tested 3 samples of Tirzepatide (GLP-1 and GIP agonist) from Paradigm Peptide between 5 Aug 2025 and 4 Sep 2025. Test scores average over 7, no score below 6, and at least 2 tests warrant a tentative Finnrick Rating of A (Great).
Finnrick Rating™
Tentative Rating
Paradigm Peptide
Tirzepatide
Tested 3 Samples
Last test 4 Sep 2025
Take Action
Researcher
Request Full Data Access to the Finnrick database of peptide tests.
Free peptide testing
Mail in a sample (US only) to get confidence for the specific vials you have, and contribute to identifying unsafe supply chains, so other people can avoid risky and costly mistakes.
Other Tirzepatide tests from top-rated vendors:
All Tirzepatide tests from Paradigm Peptide
Samples are tested in commercial labs
Tests Count
3
Scores
AVGMINMAX
Last
4 Sep 2025
First
5 Aug 2025
| Quantity | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Test Date | Certificate | Test Score | Label | Tested | Difference | Purity | Batch ID | Container | Tested At | Sent By |
| 4 Sep 2025 | View | 60mg | 62.800mg | +4.7% | 99.95% | Nv60-25 | Silver Label / Silver Crimp / Orange Cap | Lab E | Public | |
| 11 Aug 2025 | View | 30mg | 29.500mg | -1.7% | 99.95% | 7585 | Silver Label / Copper Crimp / Clear Cap | Lab E | Public | |
| 5 Aug 2025 | View | 60mg | 80.100mg | +33.5% | 99.93% | 7585 | Silver Label / Silver Crimp / Violet Cap | Lab E | Public | |